Alpine Immune Sciences, Inc. (ALPN)

NASDAQ: ALPN · IEX Real-Time Price · USD

64.55

+0.12 (0.19%)

At close: Apr 19, 2024, 4:00 PM

64.50

-0.05 (-0.08%)

After-hours: Apr 19, 2024, 7:38 PM EDT

Alpine Immune Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Equivalents	43.92	13.38	67.91	34.96	16.26	10.71	8.13	11.82	24.99	27.81	Upgrade
Short-Term Investments	283.49	224.27	94.4	70.62	24.4	41.59	73.24	0	62.26	0	Upgrade
Cash & Cash Equivalents	327.41	237.64	162.3	105.58	40.65	52.3	81.37	11.82	87.25	27.81	Upgrade
Cash Growth	37.78%	46.42%	53.72%	159.72%	-22.28%	-35.72%	588.48%	-86.45%	213.73%	673.01%	Upgrade
Receivables	0.17	0.39	25	0	0	0	0	0	0	0	Upgrade
Other Current Assets	2.46	2.96	4.71	1.52	1.65	1.24	1.18	0.04	0.43	0.63	Upgrade
Total Current Assets	330.03	240.99	192.01	107.1	42.3	53.55	82.55	11.86	87.69	28.44	Upgrade
Property, Plant & Equipment	8.99	9.8	10.55	11.19	11.54	1.2	1.09	0.74	0.22	0.1	Upgrade
Long-Term Investments	40.56	35.48	52.87	25.55	0	0	0	0	0	0	Upgrade
Goodwill and Intangibles	0	0	0	0	0	0	1.45	0	0	0	Upgrade
Other Long-Term Assets	0.27	0.41	0.47	0.25	0.25	0.13	0.13	0	0	0	Upgrade
Total Long-Term Assets	49.82	45.69	63.89	36.99	11.79	1.33	2.67	0.74	0.22	0.1	Upgrade
Total Assets	379.85	286.69	255.9	144.09	54.09	54.87	85.22	12.6	87.91	28.54	Upgrade
Accounts Payable	3.59	4.29	3.35	0.58	1.54	1.72	0.19	0.13	0.99	0.93	Upgrade
Deferred Revenue	17.22	74.76	102.6	52.98	1.44	0	0.28	2.01	0	0	Upgrade
Current Debt	0.91	4.14	5.24	3.18	0.42	2.05	1	0	0	0	Upgrade
Other Current Liabilities	20.26	-25.18	-41.41	-15.57	5.29	4.36	0.43	0.27	3.43	1.49	Upgrade
Total Current Liabilities	41.98	58	69.78	41.17	8.68	8.13	1.9	2.4	4.42	2.42	Upgrade
Long-Term Debt	9	10.09	14.39	19.42	15.94	2.16	4.04	0.11	0	0	Upgrade
Other Long-Term Liabilities	0.93	39.19	50.83	21.35	0	0	0.37	0	0	41.88	Upgrade
Total Long-Term Liabilities	9.93	49.27	65.22	40.77	15.94	2.16	4.41	0.11	0	41.88	Upgrade
Total Liabilities	51.91	107.27	135	81.93	24.62	10.28	6.31	2.52	4.42	44.3	Upgrade
Total Debt	9.91	14.22	19.63	22.6	16.36	4.2	5.03	0.11	0	0	Upgrade
Debt Growth	-30.29%	-27.55%	-13.14%	38.16%	289.15%	-16.51%	4354.87%	-	-	-	Upgrade
Retained Earnings	-256.15	-223.96	-166.2	-115.87	-87.93	-46.07	-9.38	-1.6	-148.84	-126.02	Upgrade
Comprehensive Income	0.4	-1.12	-0.27	0.05	0.01	-0.01	-0.06	0	0	0	Upgrade
Shareholders' Equity	327.94	179.42	120.9	62.16	29.47	44.59	78.92	-1.46	83.49	-15.75	Upgrade
Net Cash / Debt	317.5	223.42	142.68	82.98	24.3	48.1	76.34	11.71	87.25	27.81	Upgrade
Net Cash / Debt Growth	42.11%	56.59%	71.93%	241.55%	-49.49%	-36.99%	552.13%	-86.58%	213.73%	-	Upgrade
Net Cash Per Share	6.35	6.68	5.60	3.98	1.32	3.47	11.78	20.73	175.60	153.87	Upgrade
Working Capital	288.05	183	122.24	65.93	33.62	45.42	80.65	9.45	83.27	26.03	Upgrade
Book Value Per Share	6.56	5.37	4.75	2.98	1.60	3.22	12.18	-2.58	168.02	-87.15	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).